Immune Doublet Checkpoint Inhibition in -Mutated NSCLC: A Fire That Fails to Illuminate the Orchard.

Pham R; Arulananda S

doi:10.1016/j.jtocrr.2026.100957

← 뒤로

Immune Doublet Checkpoint Inhibition in -Mutated NSCLC: A Fire That Fails to Illuminate the Orchard.

0/5 보강

JTO clinical and research reports 📖 저널 OA 100% 2025~2026 2026 Vol.7(3) p. 100957

Pham R, Arulananda S

📖 무료 전문 🟢 PMC 전문 PMC12925085

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Pham R, Arulananda S (2026). Immune Doublet Checkpoint Inhibition in -Mutated NSCLC: A Fire That Fails to Illuminate the Orchard.. JTO clinical and research reports, 7(3), 100957. https://doi.org/10.1016/j.jtocrr.2026.100957

MLA Pham R, et al.. "Immune Doublet Checkpoint Inhibition in -Mutated NSCLC: A Fire That Fails to Illuminate the Orchard.." JTO clinical and research reports, vol. 7, no. 3, 2026, pp. 100957.

PMID 41732443 ↗

DOI 10.1016/j.jtocrr.2026.100957

같은 제1저자의 인용 많은 논문 (1)

Brief Report: Alectinib With Salvage Platinum-Taxane Chemotherapy in a Pregnant Woman With ALK-Rearranged NSCLC and Rapid Disease Progression Followed by a Successful Pregnancy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2026